TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive Cancer Centers Win Majority Of Grants In Recent NCI RFAs, Klausner Tells AACI. October 6, 2000